PARP1 and colitis: The beneficial effect of PARP1 inhibition was also confirmed in various animal models including dinitrobenzene sulfonic acid (DNBS) and trinitrobenzene sulfonic acid (TNBS) induced acute and chronic colitis and spontaneous chronic colitis developed in IL-10 knockout mice (17–20).